The official blog of the Lung Institute.
The Lung Institute Educates the Public on the Restorative Nature of Regenerative Medicine in Support of Healthy Lung Month
Tampa, Fla. (October 30, 2013) – Regenerative medicine is the latest medical technology for the promotion of healing of lung tissue affected by lung disease. The Lung Institute’s physicians have harnessed this advancement in modern medicine to bring patients with conditions like chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, chronic bronchitis and emphysema an innovative treatment choice that betters their quality of life and helps them to breathe easier.
Often, many of these patients have been told that lung transplantation is their only option, and as a result many are turning to advanced treatments such as pulmonary stem cell therapies to enhance lung function and promote healing. Here’s some information about how Stem Cell Therapies as Alternative to Lung Transplantation could be beneficial for people with chronic lung diseases.
How do Stem Cells Restore Damaged Lung Tissue?
The Lung Institute utilizes autologous stem cells, meaning those derived from the patient’s own blood or bone marrow, for treatment. These adult stem cells have the unique ability to self-renew and replicate, and they are capable of forming any type of tissue found in the human body including lung tissue.
Both stem cell therapies and lung transplantation have been proven, in many cases, to improve quality of life. However, lung transplantation is an invasive inpatient surgery that has far riskier complications and a longer recovery time.
About Lung Institute
The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 729-3065.